Current trends in the medical management of osteoradionecrosis using triple therapy. Issue 5 (June 2018)

• Record Type: Journal Article
• Authors: Dhanda, J.; Rennie, L.; Shaw, R.
• Is Part Of: British journal of oral and maxillofacial surgery. Volume 56:Issue 5(2018)
• Page Start: 401
• Page End: 405
• Publication Date: 2018-06
• Subjects: Osteoradionecrosis -- Triple therapy -- Medical management -- Trends; Mouth -- Surgery -- Periodicals; Maxilla -- Surgery -- Periodicals; Face -- Surgery -- Periodicals; Surgery, Plastic -- Periodicals; Dentistry, Operative -- Periodicals; Face -- surgery -- Periodicals; Mouth -- surgery -- Periodicals; Maxilla -- surgery -- Periodicals; Surgery, Oral -- Periodicals; Oral Surgical Procedures -- Periodicals; Dentistry, Operative -- Periodicals; Bouche -- Chirurgie -- Périodiques; Maxillaire supérieur -- Chirurgie -- Périodiques; Face -- Chirurgie -- Périodiques; Chirurgie dentaire -- Périodiques; Dentistry, Operative; Face -- Surgery; Maxilla -- Surgery; Mouth -- Surgery; Surgery, Plastic; Electronic journals; Periodicals; 617.52059
• DOI: 10.1016/j.bjoms.2018.03.009
• Languages: English
• ISSNs: 0266-4356

Abstract

Abstract: Recent guidelines from the National Institute for Health and Care Excellence (NICE) have suggested that the medical management of osteoradionecrosis (ORN) of the jaws should be used in clinical trials only, and some drugs and therapeutics committees have withdrawn funds for such prescriptions. With increased scrutiny on the use of these agents, the aims of this study were to ascertain current trends in the presentation and management of ORN, with particular focus on which agents are being used.